Sign In
Buy AMGN
$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
Amgen wins battle for Horizon Therapeutics, bolstering its rare-disease portfolio
12:47pm, Tuesday, 13'th Dec 2022 MarketWatch
Amgen Inc. is acquiring Dublin-based Horizon Therapeutics in a roughly $28 billion deal that is the biggest in the healthcare sector in 2022.
Cramers Says These 3 Big Deals Aided Monday's Market Rally: 'When Companies Start Buying Each Other At A Big Premium...'
12:43pm, Tuesday, 13'th Dec 2022 Benzinga
Prominent market commentator Jim Cramer said three corporate deals announced on Monday aided the rally seen at the beginning of the week, according to a CNBC report.
What Happened: “Mergers matt
Mirati (MRTX) Up on FDA Nod to Adagrasib for KRAS Mutated NSCLC
11:29am, Tuesday, 13'th Dec 2022 Zacks Investment Research
The accelerated approval of Mirati Therapeutics' (MRTX) Krazati is based on ORR and DOR data from the phase II registration-enabling cohort of the KRYSTAL-1 study.
Nasdaq, S&P 500 Futures Skyrocket As Consumer Price Inflation Cools Off Notably In November: Oracle, Tesla, Pinterest Among Early Movers
10:59am, Tuesday, 13'th Dec 2022 Benzinga
The index futures point to a sharply higher opening on Tuesday, as the November consumer price inflation report came in notably below October levels and the consensus expectations.
U.S. stocks launch
Amgen: 'Winner' For Horizon
09:12am, Tuesday, 13'th Dec 2022
Amgen has become the winner in the Horizon Therapeutics sale process. The deal comes at a full price, offset by synergy estimates and pipeline additions.
Tesla, Apple, Rivian, Horizon, Paypal: Why These 5 Stocks Are Drawing Investors' Attention Today
12:46am, Tuesday, 13'th Dec 2022 Benzinga
Major Wall Street indices closed over 1% higher on Monday after last week’s subdued performance. Investors are bracing for the release of the consumer price inflation data on Tuesday followed by the
Dow ends more than 500 points higher to start a week rich with inflation, central bank news
09:37pm, Monday, 12'th Dec 2022 MarketWatch
Stocks finish sharply higher to start a week that will see U.S. consumer price data on Tuesday and a rate decision by the Federal Reserve on Wednesday.
Jim Cramer says three key deals helped the market rally on Monday
07:22pm, Monday, 12'th Dec 2022
Cramer explained how three corporate deals announced on Monday helped push stocks up.
Mirati Wins FDA Approval For Amgen-Rivaling Cancer Drug As Wild Stock Swing Continues
05:52pm, Monday, 12'th Dec 2022
Mirati won FDA approval for its rival to Amgen's lung cancer drug on Monday. The approval comes as MRTX stock continues to experience wild swings.
Amgen (AMGN) to Buy Horizon Therapeutics For $27.8 Billion
05:05pm, Monday, 12'th Dec 2022 Zacks Investment Research
Amgen (AMGN) wins the race to buy Horizon Therapeutics and makes an acquisition offer of $27.8 billion.
Amgen set to acquire Horizon Therapeutics in $26.4 billion deal
04:40pm, Monday, 12'th Dec 2022
Yahoo Finance anchors Seana Smith and Jared Blikre discuss Amgen set to acquire Horizon Therapeutics for more than $26 billion as the company dives deeper into rare disease treatment.
Why Horizon Therapeutics Stock Is Soaring Today
04:06pm, Monday, 12'th Dec 2022 The Motley Fool
Amgen's planned acquisition of Horizon could close in the first half of next year.
Wall Street Awaits Key Fed FOMC Decision
03:57pm, Monday, 12'th Dec 2022 Zacks Investment Research
Wall Street Awaits Key Fed FOMC Decision
Busy Week Highlighted by Next Fed Rate Move
03:34pm, Monday, 12'th Dec 2022 Zacks Investment Research
Consensus is currently for a 50 basis point (bps) hike mid-week, which will bring the Fed funds rate over +4% for the first time in 15 years.
Amgen wins battle for Horizon Therapeutics, bolstering its rare-disease portfolio
03:05pm, Monday, 12'th Dec 2022
Amgen Inc. said Monday that it's acquiring Dublin-based Horizon Therapeutics in a roughly $28 billion deal that is the biggest in the healthcare sector in 2022.
